IBEX 35
11.076,90 +93,20 (+0,85%) Euro Stoxx 50
4.969,79 +30,78 (+0,62%) Dólar/Euro
1,0739 +0,0006 (+0,05%) Petróleo Brent
89,29 +0,28 (+0,31%) Oro
2.360,30 +17,80 (+0,76%) Bitcoin EUR
59.988,11 +493,86 (+0,83%)
Check-Cap Ltd. (CHEK)
Después del cierre:
Check-Cap Ltd.
Check-Cap Building
29 Abba Hushi Avenue PO Box 1271
Isfiya 3009000
Israel
972 4 830 3401
https://www.check-cap.com
Sector(es): Healthcare
Sector: Diagnostics & Research
Empleados a tiempo completo: 85
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Alex Ovadia | CEO & Director | 409,35k | N/A | 1962 |
| Dr. Yoav Kimchy Ph.D. | Founder & Interim CTO | 362,65k | N/A | 1961 |
| Mr. Joshua Belkar | Vice President of Operations | 269,57k | N/A | 1969 |
| Ms. Iris Even-Tov | Interim Chief Financial Officer | N/A | N/A | N/A |
| Ms. Noa Reshef M.B.A. | Director of Human Resources | N/A | N/A | N/A |
Descripción
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
Gobierno corporativo
El ISS Governance QualityScore de Check-Cap Ltd., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
